Table 2. Association between fatigue and inflammation (DAS44-CRP) at presentation with CSA in CSA-patients who later progressed to RA (A) and at RA-diagnosis (B).
CSA-onset | RA-diagnosis | |
---|---|---|
All patients | β (95% CI) 18 (7–28)a |
β (95% CI) 5 (3–7)b |
ACPA-strati?ed: | ||
ACPA+ | 25 (7–42)a | 9 (5 - 12)b |
ACPA- | 10 (-4, +25) | 2 (-1, +5) |
ACPA: anti-citrullinated protein antibody; CSA: clinically suspect arthralgia; RA: rheumatoid arthritis.
P<0.01.
P<0.001.